Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 20,752	$ 44,579
Short term investments	54,307	45,602
Prepaid expenses and other current assets	2,381	3,567
Total current assets	77,440	93,748
Assets held for sale	10	0
Property and equipment, net	234	393
Operating lease right-of-use assets	385	291
Long term investments	0	3,578
Goodwill	17,625	0
Intangible asset	63,672	5,900
Other assets	8,456	0
Equity investments in Lighthouse Pharmaceuticals, Inc.	78	0
Total assets	167,900	103,910
Current liabilities:
Accounts payable	2,033	570
Short term contingent consideration	4,103	0
Accrued expenses and other current liabilities	3,436	2,499
Total current liabilities	9,572	3,069
Long - term debt	13,429	0
Long-term operating lease liabilities	321	0
Long term contingent consideration	53,603	0
Deferred tax liabilities	5,304	248
Other long-term liabilities	587	0
Total liabilities	82,816	3,317
Commitments and contingencies (See Note 8)
Stockholders’ equity:
Preferred stock, $0.001 par value, 10,000,000 authorized (100,000 shares of which are designated as Series A Junior Participating Preferred Stock), no shares issued and outstanding as of December 31, 2023 and 2022, respectively	0	0
Common stock, $0.001 par value, 100,000,000 shares authorized, 42,973,215 and 36,136,480 issued and outstanding as of December 31, 2023 and 2022, respectively	43	36
Additional paid in capital	401,638	389,105
Accumulated other comprehensive income (loss)	3,047	(289)
Accumulated deficit	(319,644)	(288,259)
Total stockholders’ equity	85,084	100,593
Total liabilities and stockholders’ equity	$ 167,900	$ 103,910